MainImg

WebDaktarClinic,

Ai Assisted Tele-Medicine Globally, Next Generation Heathcare, Primary Care From The Reach Of Your Hut








Amsterdam, The Hague, Netherlands | European Union | Vancouver, Toronto, ON, Canada | Santa Clara, CA USA | Paris, France | Oxfordshire, Cambridgeshire, London, United Kingdom | African Union Countries | Singapore, SG | Japan | South East Asian Countries
| NZ & Australia | Developing World Countries Of Asia, Africa, Latin America, and Asia.


Statement Of Work & Deliverables, Requirement Engineering:

Tele-Medicine -Webdaktar NLP Assisted Ai Solution Architecture, - Simialr Use Case Implemented To Satisfy
Next Generation Heathcare , - Big Data Ecosystems High Level . Low Design available , For Public Heath Care, Drug Delivery, Lab Medicine,

Clients:

Government, Non Government organization of the world , World Heath Organization Scale Institutions, Healthcare industries, Physicians, Clinics, Diagnostics centers, Laboratory medicine, Pathology, Extra mural, Pandemic Heath organizations,
Insurance companies, Telecommunication companies,


1. Overview


1.1. Purpose

The solution provides Technology provisioning mechanism for serving both clinicians and scientists around the world who are working to conquer critical Disease to further the understanding, diagnosis, treatment, and prevention Disease affecting
the body and mind, by promoting research, clinical care, education, training, and advocacy.

The solution meets to select technology vendors with demonstrated capabilities in building a platform that will access, accept, and process patient data in order to further the research goals for Research Data Registry.

1.2. Timeline

The table below lists key milestones and dates that apply to this RFP.


Key Milestone Deadline
RFP Published to Vendors X 1
Questions Due to Client Y 15
Proposals Due to Client Z 28
Client Notification to Qualifying Vendors R 15
Vendor Interviews H 18-27
Selection & Notification of Selected Vendors M 27-31


1.3. Selection and Award Process

The Registry project team will evaluate all proposals and identify those that best meet project requirements. Qualifying vendors will be notified no later than March 15, 2022, and they will be invited to demonstrate their proposed solution to
Client onsite or via webinar no later than Month DAte, 2022.

2. Business Context, Background, Dates and Requirements

2.1. About Corporate /Client Registry

A mission-driven, groundbreaking initiative that is harnessing the power of big data to conquer Pandemic disease worldwide. Through the Registry, Corporation will initiate the largest shared information resource to advance collaborative research.
Pandemic Disease present unique needs, and research-focused registries offer a solution for sharing knowledge through collaboration. A single point of access for relevant information will serve as a vehicle for building a comprehensive knowledge base for diseases.
Leveraging this valuable asset will enable research to more quickly and accurately answer critical questions including disease prevalence, affected populations, and key socio-demographic data.

Through the Registry, Company demonstrates a commitment to both leveraging emerging technologies and creating novel approaches that foster breakthroughs in patient care while minimizing burdens imposed on clinicians and researchers. The Registry ensures
the creation of an ever-expanding body of actionable knowledge of benefit to researchers and clinicians worldwide, and ultimately, their patients.

Company envisions selecting multiple technology vendors to work collaboratively on various aspects of registry development.

2.2. Guiding Principles

The Com[any Registry incorporates the following guiding principles in pursuit of our objectives:


  • Research-driven and patient-focused approach: Company will build registry products with a focus on research for the purposes of improving medical care and supporting development of new cures and treatments for all diseases.
  • A focus on priority Company disease groups: The Registry will provide key data acquisition and management functions for its portfolio of company diseases and disorders that pose unique challenges for researchers and the medical community.

  • Leveraging credibility and convening power: Company possesses the credibility and convening power to collect and analyze high-quality patient data in a manner that will set new standards in the registry space and positively transform the collection and use of big data in disease research.
  • A culture of mutual respect and learning with partner institutions and other stakeholders: The company Registry will promote bi-directional learning with the stakeholders with which it interacts, working collaboratively to develop
    long-term relationships built on trust and shared value.

  • Promoting the dissemination, sharing, repurposing and use of actionable data: All data and resources will be optimized for reuse by participating institutions and for other company initiatives, through data exploration, advanced querying, and integration with tools for graphically displaying data, among other methodologies.
  • A robust strategy for acquiring and curating data: Data will be acquired through integration with electronic health records, electronic data capture (chart abstraction/online instruments and surveys), patient-reported outcomes
    (online research instruments/SMS text/IVR), and legacy dataset import, among others.
  • Building in-house capacity to serve as a repository of data and creator of knowledge:

    Company will retain access to the data for every registry project it supports, ensuring that we will build two assets simultaneously: (i) in-house expertise in the management and validation of data; and (ii), an ever-expanding body of high quality data.
  • A market-driven approach: Through on-going consultation, the company Registry will align priorities with industry partners, charitable entities, institutes and researchers, promoting a market-driven, research-centered approach.
  • Flexibility and responding to emerging opportunities and challenges: Due to the fast pace of technological and scientific developments in medicine, the company Registry will remain flexible in its approach, so as to seize opportunities as they emerge while anticipating and adapting to emerging challenges.

  • A focus on promoting self-sustainability: The company Registry will seek to be financially self-sustaining, with an anticipated five years required to achieve breakeven/crossover. It is anticipated that revenues generated from the company Registry’s research projects will offset its investments.
  • A culture of risk-taking: The compnay Registry will embrace the inherent risk in its undertakings, anticipating and attempting to mitigate risk, while also incorporating feedback loops to transform challenges into opportunities for improvement.
  • Pro-active creation of synergies: In addition to exploring research requests and invitations to partner, the Registry will actively engage with stakeholders in the medical and related fields, thereby pro-actively seeking to create synergies.

  • Complementarity to on-going efforts: The company Registry will complement and seek ways to enhance the efforts of other initiatives.
  • An emphasis on objective decision-making and vetting: To achieve its objectives efficiently, the Registry will employ unbiased, objective frameworks for assessing and prioritizing numerous potential relationships, including those with vendors, collaborators, and researchers.
  • Contributing to the broader medical and registry communities: As a recognized leader in the registry and broader medical communities, the Registry will actively engage through associations, symposia, conferences, journal articles,
    mentoring, and other means, to contribute to the broader community and provide ongoing intellectual leadership.

    2.3 Scope

    The Corporation Registry will accept patient data from a variety of sources and formats related to the diagnosis and treatment of patients with disease. The Registry will initially focus on pandemic/ disease, with plans to incorporate
    additional diseases aligning with scientific priorities as the Registry matures.

    Data collected through the Registry will support:

    1. Research (basic, clinical, epidemiological)
    2. Generating cohorts of well-characterized patients
    3. Identifying phenotypic clinical features of patients with disease
    4. Improving and/or assisting with clinical trial recruitment processes
    5. Identifying biomarkers correlated with disease
    6. Appropriate secondary uses of the aggregated data (e.g., benchmarking, quality improvement, regulatory requirements)


    3.4 Project Milestones, Deliverables, and Deadlines

    Upon selection of vendors, corporate Registry staff will assemble a Project Team consisting of internal staff and staff representing each vendor. The Project Team will develop a Project Plan specifying deliverables, milestones, timeframes,
    deadlines, and resource requirements for each stage.

    3. Requirements

    The requirements for the corporate registry project are detailed in the table below.
    Vendors are expected to respond to these requirements by replying in a survey format with additional details that at a minimum indicate the requirement is met, partially met, requires customization, or cannot be met, as well as any comments that will explain the response.
    The requirements include the following groupings for specific features:

    1. Business and System
    2. Regulations and Policies
    3. Constraints
    4. Information System Design & Integration
    5. Performance, Availability & Contingency Plan



    1. Business and System Specification


    1.1 The system will include the ability to directly integrate with multiple data sources, including electronic health records, billing systems, other registries, among others.
    1.2 The system will include the ability to handle data collection for at least two points of care with integration of multiple entries for the same episode of care.
    1.3 The system will include the ability to generate exportable data sets for use by corporate staff.
    1.4 The system will be configurable, with the ability to modify and add data elements as needed for data collection.
    1.5 The system will include canned and custom reports. Vendor comment should include details of the format (e.g. pdf, xls, csv, etc.)

    2. Regulations and Policies

    2.1 The system will conform to the federal laws and regulations that are planned for at the time of go-live related to health IT, privacy and security.
    2.2 The system will conform to the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and related regulations.

    3. Constraints

    3.1 The vendor will demonstrate the ability to import legacy data in a defined format inclusive of all required fields.
    3.2 The vendor will demonstrate the ability to incorporate different types of data (i.e. structured, semi-structured, unstructured)

    4. Information System Design & Integration

    4.1 The system will integrate with PersonnelHR, corp’s association management system to pull user-specific permissions and information through single-sign on.
    4.2 The vendor will demonstrate the ability to host the clinical data registry. Please explain your approach in some detail.
    4.3 The vendor will demonstrate the ability to support scaling the hardware and software.

    4.4 The vendor will demonstrate the ability to provide technical assistance to support multiple registries .
    4.5 The vendor will demonstrate the ability to have scheduled and routine periodic import(s) of the data that have been collected and which need to be imported. (Specify real-time, hourly, and daily).
    4.6 The system will incorporate responsive design in application front-end to allow for multi-platform and device accessibility.
    4.7 The vendor will provide data collection and reporting services with secure certificate (HTTPS) implementation if corporation will not host the solution.
    4.8 For DaaS, SaaS or hosted environments, the Vendor will provide details of the scheduled backups of data and system environments (include details of how often and when).

    5. Performance, Availability & Contingency Plan

    5.1 The system will be available online 24 hours per day, 365 days per year with the exception of scheduled and pre-notified system maintenance downtimes.
    5.2 The vendor will provide adequate tools to investigate any performance issues and system delays/outages that might be reported by users.
    5.3 For DaaS, SaaS and hosted software, the Vendor will provide details of scheduled and routine updates and outages that will occur.

    5.4 For SaaS and hosted solutions, in the event of an unscheduled outages that might occur (such as a natural disaster), the Vendor will provide details of how a continuity plan (e.g. a tested disaster and recovery plan, and solution(s)
    in place that will restore system availability).
    5.5 The vendor will demonstrate that system resources are adequate for timely report generation and that response times are acceptable.
    5.6 The vendor should include details of their ability and preferred means of providing Help Desk and service support, including non-business hours.




    Confidential,
    Ai Development Lab In Public and Primary Healthcare. - Blood & Brain Disease Research Center
    Centre For Blood Research and Genomic /inherited Blood Disease Research
    Centre for Exta-Pathological Collaboration- Inter industry Data Share
    Research Laboratory For Brain and Bacterial Meningitis
    Research Laboratory For Diabetes and CKD
    Innovation Thru Research©



    Virtual Locations: Vancovuer BC,CA (Headquartered), Singapore,SG; Sydney, Australia; Oakland, New Zealand;San Francisco,US; Toronto,ON CA; Dubai UAE; Shanghai, China; Beijing china; Seoul, South Korea; Hong Kong ,HK; Tokyo, Japan; Cambridgeshire, UK, oxfordshire, UK, London, UK;Sweden; Switzerland; EU Countires : Munich, Germany; Frankfort Germany; Le Burnel, Paris, Lyon, France; Rome, Venice, Italy;Kuwait city , Kuwait; Kuala Lumpur, Malayasia;
    Aerovition Digital Inc. comprises of 35 Independent, Cross Functional, heavily Matrix Based Collaborative Departments, Globally Distributed in: Asia, Noth America, Australia & European Union, Virtually, We provide remote Opportunity To Work & Partners' To Affiliate with us from 3000 locations around the globe, in 180 countries.